DiscoverThe Lancet Respiratory Medicine in conversation withLorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Update: 2025-07-16
Share

Description

This episode is in Italian. For the English version, please see the main feed.

Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente.

Leggi l'articolo completo:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

The Lancet Group